CANNAPHARMARX, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $17.5M | $8.7M | $335.0K |
| FY2021 | $13.0M | $114.3K | $27.8K |
| FY2022 | $22.8M | $5.4M | $2.3K |
| FY2023 | $23.9M | $11.7M | $650 |
| FY2024 | $30.6M | $10.8M | $2.2K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $17.5M | $8.7M | $335.0K |
| FY2021 | $13.0M | $114.3K | $27.8K |
| FY2022 | $22.8M | $5.4M | $2.3K |
| FY2023 | $23.9M | $11.7M | $650 |
| FY2024 | $30.6M | $10.8M | $2.2K |